Clincosm LogoSign in Get a demo

Leukemia, Myelomonocytic, Chronic

Showing 1 - 23 of 23
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immune System Diseases, Autoimmune Diseases, Inflammation Trial (observational cohort study)

Not yet recruiting
  • Immune System Diseases
  • +15 more
  • observational cohort study
  • (no location specified)
Jul 23, 2023

MDS, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic Trial in Newcastle (Subcutaneous azacitidine, Oral

Not yet recruiting
  • Myelodysplastic Syndromes
  • +3 more
  • Subcutaneous azacitidine
  • Oral decitabine/cedazuridine
  • Newcastle, New South Wales, Australia
    Calvary Mater Newcastle
May 29, 2023

Myelodysplastic Syndrome, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute Trial in Worldwide (Azacitidine,

Active, not recruiting
Has Results
  • Myelodysplastic Syndrome
  • +2 more
  • Daphne, Alabama
  • +241 more
Dec 23, 2022

MDS, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute Trial in Worldwide (Azacitidine, Pevonedistat)

Completed
Has Results
  • Myelodysplastic Syndromes
  • +2 more
  • Birmingham, Alabama
  • +58 more
Aug 24, 2022

Azacitidine in International Prognostic Scoring System

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
    • Hefei, Anhui, China
    • +16 more
    Sep 6, 2022

    MDS, Leukemia, Myelomonocytic, Chronic Trial (decitabine, Spartalizumab, Sabatolimab)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • Leukemia, Myelomonocytic, Chronic
    • (no location specified)
    Aug 5, 2022

    Primary Myelofibrosis, Polycythemia Vera, Essential Thrombocythemia Trial in Toronto (Observational)

    Recruiting
    • Primary Myelofibrosis
    • +9 more
    • Observational
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Apr 11, 2022

    Leukemia, Myeloid, Acute, MDS, Leukemia, Myelomonocytic, Chronic Trial in Worldwide (H3B-8800 (RVT-2001))

    Recruiting
    • Leukemia, Myeloid, Acute
    • +2 more
    • H3B-8800 (RVT-2001)
    • Stanford, California
    • +26 more
    Mar 23, 2022

    MDS, Leukemia, Myelomonocytic, Chronic Trial in Worldwide (Guadecitabine, Treatment Choice)

    Completed
    • Myelodysplastic Syndromes
    • Leukemia, Myelomonocytic, Chronic
    • Duarte, California
    • +95 more
    Sep 1, 2021

    Leukemia, Myelomonocytic, Chronic Trial in United States (Tipifarnib)

    Completed
    • Leukemia, Myelomonocytic, Chronic
    • Scottsdale, Arizona
    • +7 more
    May 12, 2021

    Leukemia, Myeloid, Acute, MDS, Leukemia, Myelomonocytic, Chronic Trial in Duesseldorf (Lenalidomide, Azacitidine, Donor

    Completed
    • Leukemia, Myeloid, Acute
    • +2 more
    • Duesseldorf, NRW, Germany
      University Hospital Duesseldorf, Dept. of Hematology, Oncology a
    May 26, 2020

    Recently Diagnosed Myelodysplastic Syndrome/Chronic

    Completed
    • Myelodysplastic Syndrome
    • Leukemia, Myelomonocytic, Chronic
    • Either Wait and See, or Supportive Treatment, or Active Treatment at physician discretion
    • Vitoria, Alava, Spain
    • +49 more
    Jan 23, 2020

    MDS, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute Trial in United States (oral azacitidine)

    Completed
    • Myelodysplastic Syndromes
    • +2 more
    • oral azacitidine
    • La Jolla, California
    • +7 more
    Nov 7, 2019

    Acute Myeloid Leukemia, MDS, Lymphoma Trial in United States (azacitidine)

    Completed
    • Acute Myeloid Leukemia
    • +4 more
    • Greenbrae, California
    • +10 more
    Nov 6, 2019

    Patients Receiving Azacitidine in Daily Clinical Practice in

    Completed
    • Myelodysplastic Syndromes
    • +2 more
      • (no location specified)
      Jul 23, 2019

      Acute Myeloid Leukemia, MDS, Agnogenic Myeloid Metaplasia Trial in Houston (Dasatinib (BMS-354825))

      Completed
      Has Results
      • Acute Myeloid Leukemia
      • +7 more
      • Dasatinib (BMS-354825)
      • Houston, Texas
        The University of Texas M.D. Anderson Cancer Center
      May 2, 2019

      MDS, Leukemia, Myelomonocytic, Chronic Trial in France, Germany (Azacitidine, Volasertib)

      Terminated
      Has Results
      • Myelodysplastic Syndromes
      • Leukemia, Myelomonocytic, Chronic
      • Marseille, France
      • +13 more
      Sep 11, 2018

      MDS, Leukemia, Myelomonocytic, Chronic Trial in Japan (Azacitidine, Volasertib)

      Completed
      Has Results
      • Myelodysplastic Syndromes
      • Leukemia, Myelomonocytic, Chronic
      • Aichi, Nagoya, Japan
      • +3 more
      Oct 23, 2017

      Leukemia, Myelomonocytic, Chronic Trial in Gothenburg, Stockholm (Cohort 1, Ceplene® and Proleukin®, Cohort 2, Ceplene® and

      Unknown status
      • Leukemia, Myelomonocytic, Chronic
      • Cohort 1, Ceplene® and Proleukin®
      • +2 more
      • Gothenburg, Sweden
      • +1 more
      Dec 18, 2017

      MDS, Leukemia, Myelomonocytic, Chronic, Angiogenesis Trial in Toronto (Lenalidomide and melphalan)

      Completed
      • Myelodysplastic Syndromes
      • +2 more
      • Lenalidomide and melphalan
      • Toronto, Ontario, Canada
        Sunnybrook Health Sciences Centre, Odette Cancer Center
      Jun 8, 2017

      GVHD, MDS, Leukemia Trial run by the NHLBI (RFT5-SMPT-dgA, Isolex system)

      Completed
      Has Results
      • Graft vs Host Disease
      • +9 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Sep 21, 2016

      Korean Post-marketing Surveillance for Sprycel®

      Completed
      • Leukemia, Myelomonocytic, Chronic
      • Leukemia-Lymphoma
        • Seoul, Korea, Republic of
          Local Institution
        Apr 25, 2016

        MDS, Leukemia, Myelomonocytic, Chronic Trial in Durham (Sorafenib)

        Terminated
        Has Results
        • Myelodysplastic Syndromes
        • Leukemia, Myelomonocytic, Chronic
        • Durham, North Carolina
          Duke University Medical Center
        Mar 21, 2016